HKD 7.71
(0.13%)
Year | Net Income | Net Income Growth |
---|---|---|
2023 | 30.03 Million CNY | 270.5% |
2022 | -17.61 Million CNY | -122.3% |
2021 | 79.01 Million CNY | -0.1% |
2020 | 79.09 Million CNY | 166.4% |
2019 | 29.69 Million CNY | 0.0% |
Year | Net Income | Net Income Growth |
---|---|---|
2024 Q2 | 18.48 Million CNY | 0.0% |
2024 Q1 | 18.48 Million CNY | 827.88% |
2023 FY | 30.03 Million CNY | 270.5% |
2023 Q1 | 17.55 Million CNY | 199.15% |
2023 Q4 | -2.53 Million CNY | 0.0% |
2023 Q3 | -2.53 Million HKD | -114.46% |
2023 Q2 | 17.55 Million CNY | 0.0% |
2022 Q2 | 8.9 Million CNY | 0.0% |
2022 Q1 | 8.9 Million CNY | -59.27% |
2022 FY | -17.61 Million CNY | -122.3% |
2022 Q4 | -17.7 Million CNY | 0.0% |
2022 Q3 | -17.7 Million CNY | -298.98% |
2021 Q1 | 17.65 Million CNY | 0.0% |
2021 FY | 79.01 Million CNY | -0.1% |
2021 Q4 | 21.85 Million CNY | 0.0% |
2021 Q3 | 21.85 Million CNY | 23.75% |
2021 Q2 | 17.65 Million CNY | 0.0% |
2020 FY | 79.09 Million CNY | 166.4% |
2019 FY | 29.69 Million CNY | 0.0% |
Name | Net Income | Net Income Difference |
---|---|---|
Life Healthcare Group Limited | 15.81 Million HKD | -89.898% |
China Biotech Services Holdings Limited | -95.44 Million HKD | 131.471% |